← Home / Moolec Science SA (MLEC)
Stock Analysis

Moolec Science SA (MLEC)

MLEC
MLEC · Healthcare • Biotechnology
7.00 +0.57%
Track MLEC in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when MLEC price is:
52W Range Position
14%
LOWMIDHIGH
Trend
Vulnerable
Momentum
Neutral
Updated: 2026-08-24 02:43 UTC
WOI Investment Thesis
Vulnerable
Current market structure would strengthen above 7.48. Holding above 6.59 preserves the current price structure.
⚖️
✓
Fundamentals
Moderate / Negative
✓
Price Structure
Vulnerable
•
Momentum
Neutral
×
Current Resistance
Below Resistance
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
6.59
↗
Break Above
No setup-specific trigger is available; nearest structural resistance is shown.
7.48
🎯
Next Objective
No defined objective is currently available for the primary technical setup.
Not available
×
Thesis Break
No setup-specific invalidation level is currently defined.
Not available
What's Driving MLEC?
• No active technical setup
Momentum is Neutral. No qualified technical setup is currently active.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 6.59 would weaken the current structure.
Full Analysis Workspace
Technical Signal
No Active Technical Setup
•
No qualified technical setup is currently active.
RSI(14)
47.4
◎
How to read this setup
The next meaningful technical decision is likely to occur between support at 6.59 and resistance at 7.48. A move through resistance would be needed to materially improve the chart, while a break of support would keep the pressure side dominant.
Price Chart
MLEC — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Classic valuation · Ratios use trailing twelve months
Updated 2026-08-21
Spec
Speculative premium
Valuation is very demanding relative to current fundamentals; expectations are high.
Market Cap
$5.1M
Company size
P/S
48.0
Very high
P/B
10.0
Premium
Not financial advice
Business Lens
Financial pressure is elevated
Financial conditions require selective monitoring.
↗
Revenue Growth
Moderate
●
Profitability
Negative
≈
Cash Flow
Pressured
⚖
Balance Sheet
Pressured
💵 Revenue
2.64M
≈ Moderate
📈 Net Income
-2.43M
↘ Negative
🧮 EPS (Basic)
-0.06
↘ Negative
Moolec Science SA
Healthcare • Biotechnology
You Might Also Like